Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
Shopping Cart: ( empty )
You are here: Home > Journals > SH > SH05044
RESEARCH ARTICLE
Contents Vol 3(4)

Prevalence and risk factors for lifetime exposure to Pap smear abnormalities in the Australian community

T. Natasha Posner A F , Frances M. Boyle B , David M. Purdie C , Michael P. Dunne D and Jake M. Najman E
+ Author Affiliations
- Author Affiliations

A Department of Primary Care and General Practice, Clinical Sciences Building, University of Birmingham, Edgbaston B15 2TT, UK.

B School of Population Health, The University of Queensland, Level 3 Edith Cavell Building, Herston Road, Herston, Qld 4029, Australia.

C Population and Clinical Sciences Division, Queensland Institute of Medical Research, Herston, Qld 4006, Australia.

D School of Public Health, Queensland University of Technology, Kelvin Grove Campus, Victoria Park Road, Kelvin Grove, Qld 4059, Australia.

E Schools of Population Health and Social Science, The University of Queensland, Herston, Qld 4006, Australia.

F Corresponding author. Email: posnertr@adf.bham.ac.uk

Sexual Health 3(4) 275-279 https://doi.org/10.1071/SH05044
Submitted: 26 August 2005  Accepted: 8 June 2006   Published: 17 November 2006

Abstract

Background: This study examined the prevalence, correlates and consequences of abnormal Pap smears in a population-based survey of sexuality and health in the Australian community. Methods: Cross-sectional telephone survey of 908 women aged 18–59 years randomly selected from the Commonwealth electoral roll. Results: Most women (91%) reported having had at least one Pap smear test, a figure directly comparable with national estimates. Being single (prevalence ratio (PR) 4.61; 95% CI 2.09–10.17) and not having had sexual intercourse (PR 5.31, 95% CI 3.11–9.07) were strong predictors of never having been tested. One in four women (26%) who reported being screened also reported having had an abnormal Pap smear result, of whom 66% said they had further testing and 52% some form of treatment. A minority (19%) reported negative effects of treatment on their sex lives. Having been diagnosed with human papillomavirus (HPV) (PR 2.87, 95% CI 1.84–4.48), and to a lesser degree, having had a greater number of male sexual partners (PR 1.38, 95% CI 1.01–1.89), and experiencing sexual problems in the last year (PR 0.99, 95% CI 0.99–1.88) were independently associated with reporting of abnormal Pap smear results. Conclusions: Approximately one in four women self report lifetime exposure to Pap smear abnormalities. It is important that women are well prepared for this common experience. A causal association between multiple sexual partners and risk of acquiring HPV infection is supported by these data.

Additional keywords: abnormal results, cervical screening, HPV, population-based survey.


Acknowledgements

This research was funded by the NHMRC. We thank the participants and interviewers, and especially Michelle Cook and Andrea Lanyon for supervising the data collection process. Dr Margot Legosz and Dixie Statham provided valuable advice in the early stages. We also thank the reviewers for their helpful comments and suggestions.


References


[1] Report of the steering group on quality assurance in screening for the prevention of cancer of the cervix. Making the Pap smear better. Canberra: Australian Government Publishing Service; 1993.

[2] National Health and Medical Research Council (NHMRC). Clinical practice guidelines. The management of women with screen detected abnormalities. Canberra: Australian Government Publishing Service; 1994.

[3] Performance standards for Australian laboratories reporting cervical cytology. Canberra: Australian Government Publishing Service; 1996.

[4] National Health and Medical Research Council (NHMRC). Screening to prevent cervical cancer. Guidelines for the management of asymptomatic women with screen detected abnormalities. Canberra: NHMRC; 2005. Available online at: http://www.nhmrc.gov.au/publications/synopses/wh39syn.htm [verified October 2006].

[5] Australian Institute of Health and Welfare (AIHW). AIHW Cat No 22. Cancer Series number 27. Cervical screening in Australia 2001–2002. Canberra: AIHW; 2004.

[6] Farnsworth A,  Mitchell HS. Prevention of cervical cancer. Med J Aust 2003; 178 653–4.
| PubMed | [verified November 2006].

[8] Kavanagh AM,  Santow G,  Mitchell H. Consequences of current patterns of Pap smear and colposcopy use. J Med Screen 1996; 3 29–34.
| PubMed |

[9] Purdie DM,  Dunne MP,  Boyle FM,  Cook MD,  Najman JM. Health and demographic characteristics of volunteers in an Australian national sexuality survey: Comparison with population norms. J Epidemiol Community Health 2002; 56 748–53.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[10] Lee J. Odds ratio or relative risk for cross-sectional data? Int J Epidemiol 1994; 23 201–3.
| PubMed |

[11] Statistical package for the social sciences [computer program]. Version 10. Chicago: SPSS Inc., 2002.

[12] Australian Bureau of Statistics (ABS). Catalogue No. 4364.0. National Health Survey: summary of results. Canberra: ABS; 2001.

[13] Laumann EO,  Paik A,  Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281 537–44.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[14] Raffle AE,  Alden B,  Quinn M,  Babb PJ,  Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003; 326 901–5.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[15] Newell SA,  Girgis A,  Sanson-Fisher RW,  Savolainen NJ. The accuracy of self-reported health behaviours and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. Am J Prev Med 1999; 17(3): 211–29.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[16] Posner T , Vessey M . Prevention of cervical cancer: the patient’s view. London: King’s Fund; 1988.

[17] Campion MJ,  Brown JR,  McCance DJ,  Atia W,  Edwards R,  Cuzick J, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988; 95 175–81.
| PubMed | | PubMed |

[18] Marteau T,  Walker P,  Giles J,  Smail M. Anxieties in women undergoing colposcopy. BJOG 1990; 97 859–61.


[19] Rogstad KE. The psychological impact of abnormal cytology and colposcopy. BJOG 2002; 109 364–8.
| PubMed |

[20] Posner T. Ethical issues and the individual woman in cancer screening programmes. J Ad Health Nurs Care 1993; 2(3): 55–69.


[21] Dickinson JA. Cervical screening: time to change the policy. Med J Aust 2002; 176 547–50.
| PubMed |

[22] Wilson S,  Lester H. How can we develop a cost-effective quality cervical screening programme? Br J Gen Pract 2002; 52 485–90.
| PubMed |